Renal Safety of Tenofovir in HIV-infected Children: A Prospective, 96-Week Longitudinal Study

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.27, Iss.8, 2007-01, pp. : 573-581

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Renal Safety of Tenofovir Disoproxil Fumarate in Vertically HIV-Infected Children, Adolescents and Young Adults: A 60-Month Follow-Up Study

By Viganò Alessandra

Clinical Drug Investigation, Vol. 31, Iss. 6, 2011-06 ,pp. : 407-415

Adis International

Access to resources Recommend Favorite

Long-Term Evaluation of Glucose Homeostasis in a Cohort of HAART-Treated HIV-Infected Children: A Longitudinal, Observational Cohort Study

By Viganò Alessandra

Clinical Drug Investigation, Vol. 29, Iss. 2, 2009-01 ,pp. : 101-109

Adis International

Access to resources Recommend Favorite

Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patients

By Gazzard Brian G

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 793-802

Informa Healthcare

Access to resources Recommend Favorite

Tenofovir Plus Didanosine as Nrti Backbone in HIV-Infected Subjects

Current Medicinal Chemistry, Vol. 13, Iss. 23, 2006-10 ,pp. : 2789-2793

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic complications of antiretroviral therapy in HIV-infected children

By Eley Brian

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 1, 2008-01 ,pp. : 37-49

Informa Healthcare

Access to resources Recommend Favorite